Bliss GVS Pharma: The Outcome of the Board Meeting held on September 28, 2026 pursuant to the Change in Control of the Company
Bliss GVS Pharma (BLISSGVS) filed a disclosure titled "The Outcome of the Board Meeting held on September 28, 2026 pursuant to the Change in Control of the Company". The company is valued at about ₹7,823 crore.
What happened
Bliss GVS Pharma (BLISSGVS) filed a disclosure with the exchanges on 28 September 2026 at 08:32 PM titled "The Outcome of the Board Meeting held on September 28, 2026 pursuant to the Change in Control of the Company".
Company snapshot
Bliss GVS Pharma is a small-cap company, with a market value of about ₹7,823 crore.
The stock last traded at ₹737.7, against a 52-week range of ₹118–₹739.9 (0.3% below the high).
Before this filing the shares had moved +25.8% over the month and +30.6% over three months. Average daily turnover over the last 20 sessions was about ₹21 crore.
Promoters held 35.01% at the end of Q1 FY27, down 0.35% points from the previous quarter. Foreign institutions owned 8.07% and domestic institutions 9.47%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 207 | 43 | 4.08 |
| Q2 FY26 | 244 | 27.3 | 2.58 |
| Q3 FY26 | 218 | 23.3 | 2.2 |
| Q4 FY26 | 257 | 35.6 | 3.37 |
| Q1 FY27 | 286 | 50.1 | 4.73 |
What history shows
This is not the company's first management change disclosure: BCEIE has 5 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 1.7% on average the next trading day and was down 3.3% on average after five days (3 filings with price data).
Market-wide, 3,833 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 24 Jul 2026 | Management change | −3.1% | +0.4% |
| 15 Jul 2026 | Management change | −3.1% | −14.0% |
| 3 Jul 2026 | Appointment of Mr Rahul Adakmol as Chief Executive Officer of the… | +1.2% | +3.6% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
In the news
Recent coverage elsewhere (links open the original publisher):
- Bliss GVS Pharma Share Price
- Price Band Hitters, September 28, 2026 at 12:00 PM IST: Bliss GVS Pharma, Sunflag, Lalithaa Jewellery, Rehtan TMT
- Anupam Rasayan files draft offer for Bliss GVS
- Bliss GVS Pharma Share Price Today: 5% Decline Analysis
- Upto 360% Jump In One Year: Why Small-Cap Pharma Stocks Like Bliss GVS, Shilpa Medicare, Others Are Beating Large Caps?
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.